A Propensity-Matched Nested Case-Control Study of Acute Coronary Syndrome Patients Genotyped for CYP2C19
Kate Kilpatrick, Nick James, Kevin Smith, John Mackay, Phillip Shepherd, Luke Boyle, Quentin Thurier, Zina Ayar, Patrick A. Gladding
This study evaluates the outcomes of acute coronary syndrome patients genotyped for CYP2C19, comparing personalized antiplatelet therapy with ticagrelor and clopidogrel.
Heart Lung and Circulation · Jan 1, 2018Peer-reviewedGenetic & Genomic Medicine